Health Care & Life Sciences » Biotechnology | Matinas BioPharma Holdings Inc.

Matinas BioPharma Holdings Inc. | Cash Flow


No data

About Matinas BioPharma Holdings

View Profile
Address
1545 Route 206 South
Bedminster New Jersey 07921
United States
Employees -
Website http://www.matinasbiopharma.com
Updated 07/08/2019
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its LNC platform technology. The company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins, and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. Its lead anti-fungal product candidate, MAT2203, delivers broad-spectrum fungicidal agent, amphotericin B; and is being developed to prevent invasive fungal infections in patients with acute lymphoblastic leukemia.